Vibha Jawa

2.5k total citations
46 papers, 1.8k citations indexed

About

Vibha Jawa is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vibha Jawa has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 34 papers in Molecular Biology and 33 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vibha Jawa's work include Monoclonal and Polyclonal Antibodies Research (33 papers), Biosimilars and Bioanalytical Methods (26 papers) and Protein purification and stability (24 papers). Vibha Jawa is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (33 papers), Biosimilars and Bioanalytical Methods (26 papers) and Protein purification and stability (24 papers). Vibha Jawa collaborates with scholars based in United States, United Kingdom and Switzerland. Vibha Jawa's co-authors include Narendra Chirmule, Bernd Meibohm, Marisa K. Joubert, Anne S. De Groot, Linda O. Narhi, Meghana Deshpande, Harald Kropshofer, Lei Zhou, Theresa J. Goletz and Eric Wakshull and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Vibha Jawa

45 papers receiving 1.7k citations

Peers

Countries citing papers authored by Vibha Jawa

Since Specialization

Citations

This map shows the geographic impact of Vibha Jawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vibha Jawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vibha Jawa more than expected).

Fields of papers citing papers by Vibha Jawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vibha Jawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vibha Jawa. The network helps show where Vibha Jawa may publish in the future.

Co-authorship network of co-authors of Vibha Jawa

This figure shows the co-authorship network connecting the top 25 collaborators of Vibha Jawa. A scholar is included among the top collaborators of Vibha Jawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vibha Jawa. Vibha Jawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines 2023 ·Journal of Pharmaceutical Sciences ·(unknown), Amitabh Gaur, Ipshita Menon, Narendra Chirmule, Priyal Bagwe, (unknown), (unknown), (unknown), (unknown), Vibha Jawa	1
2	Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium 2022 ·The AAPS Journal ·(unknown), Mohamed Hassanein, Michael A. Partridge, Vibha Jawa, Johanna Mora, Josiah Ryman, (unknown), (unknown), (unknown), (unknown), Charles Hottenstein, Robert Kubiak, Viswanath Devanarayan	17
3	Use of In Vitro Human Skin Models to Assess Potential Immune Activation In Response to Biotherapeutic Attributes and Process-related Impurities 2022 ·Journal of Pharmaceutical Sciences ·Joshua M. Tokuda, Jiansong Xie, Vibha Jawa, (unknown), John Ferbas, Nathan H. Joh, Marisa K. Joubert	7
4	Identification and characterization of a residual host cell protein hexosaminidase B associated with N ‐glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product 2021 ·Biotechnology Progress ·Xuanwen Li, Yan An, Jing Liao, Li Xiao, Michael D. Swanson, Kirby Martinez‐Fonts, (unknown), Edward C. Sherer, Vibha Jawa, Fengqiang Wang, Xinliu Gao, Simon Letarte, Douglas D. Richardson	29
5	Competition-Based Cell Assay Employing Soluble T Cell Receptors to Assess MHC Class II Antigen Processing and Presentation 2021 ·The AAPS Journal ·(unknown), (unknown), Vibha Jawa, Jad Maamary	4
6	Prevalence of Pre-Existing Neutralizing Antibodies Against Adeno-Associated Virus Serotypes 1, 2, 5, 6, 8, and 9 in Sera of Different Pig Strains 2021 ·Human Gene Therapy ·Yan‐Shan Dai, Uma Kavita, Margit H. Lampen, (unknown), (unknown), Paul Lévesque, Alexander Kozhich, Renuka Pillutla, Yan Zhang, Vibha Jawa, Leonard P. Adam	10
7	10 ^th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals 2020 ·mAbs ·Sophie Tourdot, (unknown), Juliana Bessa, Philippe Broët, Anna Fogdell‐Hahn, Mario Giorgi, Vibha Jawa, Klaudia Kuranda, Nicolas Legrand, (unknown), João Pedras-Vasconcelos, (unknown), Paula Salmikangas, David W. Scott, Veerle Snoeck, (unknown), Sebastian Spindeldreher, Daniel Kramer	9
8	The Impact of Product and Process Related Critical Quality Attributes on Immunogenicity and Adverse Immunological Effects of Biotherapeutics 2020 ·Journal of Pharmaceutical Sciences ·Yi Wen, Vibha Jawa	31
9	T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 2020 ·Frontiers in Immunology ·Vibha Jawa, Frances Terry, Jochem Gokemeijer, Shibani Mitra‐Kaushik, Brian Roberts, Sophie Tourdot, Anne S. De Groot	94
10	Silicone Oil Particles in Prefilled Syringes With Human Monoclonal Antibody, Representative of Real-World Drug Products, Did Not Increase Immunogenicity in In Vivo and In Vitro Model Systems 2019 ·Journal of Pharmaceutical Sciences ·Nathan H. Joh, Lisa Thomas, (unknown), Alla Verlinsky, (unknown), (unknown), Vibha Jawa, Shawn Cao, Linda O. Narhi, Marisa K. Joubert	25
11	Assessment of Romiplostim Immunogenicity in Adult Patients in Clinical Trials and in a Global Registry 2018 ·Blood ·(unknown), (unknown), Vibha Jawa, June Myung Kim, Daniel T. Mytych, Joseph Park, David J. Kuter	3
12	How Close Are We to Profiling Immunogenicity Risk Using In Silico Algorithms and In Vitro Methods?: an Industry Perspective 2017 ·The AAPS Journal ·Jochem Gokemeijer, Vibha Jawa, Shibani Mitra‐Kaushik	34
13	Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins 2017 ·Journal of Pharmaceutical Sciences ·Lora Hamuro, Grzegorz Kijanka, Francis Kinderman, Harald Kropshofer, (unknown), Monica L. Zepeda, Vibha Jawa	63
14	Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins 2016 ·The AAPS Journal ·Steven J. Kathman, Theingi M. Thway, Lei Zhou, Stephanie J. Lee, Steven Yu, Mark Ma, (unknown), Vibha Jawa	9
15	Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges 2016 ·Journal of Pharmaceutical Sciences ·Wim Jiskoot, Grzegorz Kijanka, Theodore W. Randolph, John F. Carpenter, Atanas V. Koulov, Hanns‐Christian Mahler, Marisa K. Joubert, Vibha Jawa, Linda O. Narhi	85
16	Development of a Human Antibody Tolerant Mouse Model to Assess the Immunogenicity Risk Due to Aggregated Biotherapeutics 2013 ·Journal of Pharmaceutical Sciences ·(unknown), Vibha Jawa, Marisa K. Joubert, Arunan Kaliyaperumal, Catherine M. Eakin, (unknown), Oscar Pan, Jilin Sun, Martha Hokom, Theresa J. Goletz, Jette Wypych, Lei Zhou, Bruce A. Kerwin, Linda O. Narhi, Taruna Arora	41
17	Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses 2012 ·Journal of Biological Chemistry ·Marisa K. Joubert, Martha Hokom, Catherine M. Eakin, Lei Zhou, Meghana Deshpande, Matthew Baker, Theresa J. Goletz, Bruce A. Kerwin, (unknown), Linda O. Narhi, Vibha Jawa	203
18	Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics 2010 ·Clinical Immunology ·(unknown), Lei Zhou, (unknown), (unknown), Theresa J. Goletz, Steven J. Swanson, Narendra Chirmule, Vibha Jawa	67
19	Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects 2010 ·Annals of Hematology ·Vibha Jawa, Martha Hokom, Zheng Hu, (unknown), Zhuang Yao, Dietmar Berger, Shalini Gupta, Steven J. Swanson, Narendra Chirmule	23
20	Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein 2007 ·Clinical Immunology ·Eugen Koren, Anne S. De Groot, Vibha Jawa, Kevin D. Beck, T. Boone, (unknown), (unknown), Daniel T. Mytych, Mirna Koscec, (unknown), Steven J. Swanson, William Martin	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact